These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6373546)

  • 1. The effect of sulphonylurea therapy on in vivo insulin sensitivity in non-insulin dependent diabetics.
    Ponchner M; Taylor R; Heine R; Alberti KG
    Horm Metab Res; 1984 Apr; 16(4):208. PubMed ID: 6373546
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of sulphonylurea therapy on insulin sensitivity in non insulin dependent diabetics.
    Khandekar S; Sethi BK; Dash RJ
    J Assoc Physicians India; 1990 Jul; 38(7):469-71. PubMed ID: 2127273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin resistance and combined therapy with sulfonylurea and insulin in non-insulin dependent diabetics].
    Vozár J
    Vnitr Lek; 1995 Feb; 41(2):141-5. PubMed ID: 7725640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Testing insulin and sulfonylurea sensitivity in type II diabetes mellitus].
    Holländer E
    Orv Hetil; 1984 Dec; 125(51):3103-6. PubMed ID: 6392996
    [No Abstract]   [Full Text] [Related]  

  • 5. [The incidence of the secondary failure of sulfonylurea therapy. Epidemiological research].
    Thoelke H; Ratzmann KP
    Dtsch Med Wochenschr; 1989 Apr; 114(15):580-3. PubMed ID: 2649348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination sulfonylurea-insulin therapy in the treatment of noninsulin-dependent diabetes mellitus.
    Rosenblatt J
    Conn Med; 1991 Nov; 55(11):634-6. PubMed ID: 1790695
    [No Abstract]   [Full Text] [Related]  

  • 7. Sulphonylurea in combination with insulin therapy: does it make sense? A review.
    Kyllästinen M
    Ann Clin Res; 1983; 15 Suppl 37():29-32. PubMed ID: 6383182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance determines efficacy of glimepiride in Type 2 diabetic patients not well controlled by diet alone.
    Shimizu H; Monden T; Nagai T; Shoda Y; Sato T; Yamada M; Mori M
    Diabet Med; 2005 Feb; 22(2):225-6. PubMed ID: 15660744
    [No Abstract]   [Full Text] [Related]  

  • 9. [Factors responsible for fasting hyperglycemia in the non-insulin-dependent diabetic patient].
    Tappy L
    Rev Med Suisse Romande; 1993 Sep; 113(9):699-701. PubMed ID: 8210897
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapeutic management of the secondary failure of sulfonylurea therapy].
    Sauer H
    Dtsch Med Wochenschr; 1985 Jan; 110(1):27-30. PubMed ID: 3880697
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined chlorpropamide-insulin in the treatment of non-insulin-dependent diabetes mellitus with secondary failure of sulfonylurea therapy.
    Jiraratsatit J; Keoplung M; Chumsilp L; Chomchoengpatya P; Matayabun S
    J Med Assoc Thai; 1986 Dec; 69(12):627-34. PubMed ID: 3553408
    [No Abstract]   [Full Text] [Related]  

  • 12. [Our experience in treating diabetes mellitus with the preparation Minidiab].
    Tsanev A; Lazarov G; Manolov D; Daskalova I; Kolebinov N
    Vutr Boles; 1988; 27(2):89-93. PubMed ID: 3414105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Transdermal administration of insulin in type II diabetics. Results of a clinical pilot study].
    Liedtke RK; Sorger M; Merk F; Vetter H
    Arzneimittelforschung; 1990 Aug; 40(8):884-6. PubMed ID: 2242080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of type 2 diabetes mellitus with special reference to metformin therapy.
    Campbell IW
    Diabete Metab; 1991 May; 17(1 Pt 2):191-6. PubMed ID: 1936475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin as a first-line therapy in type 2 diabetes: should the use of sulfonylureas be halted?
    Standl E; Schnell O
    Diabetes Care; 2008 Feb; 31 Suppl 2():S136-9. PubMed ID: 18227474
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological regulation of blood glucose levels in non-insulin-dependent diabetes mellitus.
    Bressler R; Johnson DG
    Arch Intern Med; 1997 Apr; 157(8):836-48. PubMed ID: 9129543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
    Keller U; Müller R; Berger W
    Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of poorly regulated non-insulin-dependent diabetes mellitus with combination insulin-sulfonylurea.
    Allen BT; Feinglos MN; Lebovitz HE
    Arch Intern Med; 1985 Oct; 145(10):1900-3. PubMed ID: 3899039
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type II diabetic subjects with secondary failure: treatment with prebreakfast mixed ultralente and regular insulin with a sulfonylurea.
    Kabadi UM; Kabadi MU
    J Fam Pract; 1991 Oct; 33(4):349-53. PubMed ID: 1919450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.